The global sore throat lozenges market is projected to be valued at USD 4.4 billion in 2024 and is expected to grow at a CAGR of 5.6%, reaching an estimated value of approximately USD 7.5 billion by ...
UBS cuts Croda International price target to 5,100 (5,300) pence - 'buy' UBS cuts Vistry price target to 605 (880) pence - 'sell' JPMorgan cuts DCC price target to 6,400 (6,700) pence - 'overweight' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback